Journal: ESC Heart Failure
Article Title: Sacubitrilat exerts potent antiarrhythmic effects through activation of natriuretic peptide receptor-C
doi: 10.1093/eschf/xvag253
Figure Lengend Snippet: Effects of CNP and Sac ± Ocn on caffeine induced calcium transients. ( A–D ) CNP alone and in combination with Ocn did not significantly influence caffeine-induced Ca 2+ -transient amplitude (ATX-II vs ATX-II + CNP: ΔF 405 /F 485 : 0.21 ± 0.017 vs 0.25 ± 0.036, n cells/hearts = 17/5 vs 11/4, P = .08; ATX-II vs ATX-II + CNP + Ocn: ΔF 405 /F 485 : 0.21 ± 0.02 vs 0.21 ± 0.02, n cells/hearts = 17/5 vs 17/5, P = .43), RT-50 (ATX-II vs ATX-II + CNP: 0.6 ± 0.005 s vs 0.82 ± 0.1 s, n cells/hearts = 17/5 vs 11/4, P = .41; ATX-II vs ATX-II + CNP + Ocn: 0.6 ± 0.05 s vs 0.79 ± 0.08 s, n cells/hearts = 17/5 vs 17/5, P = .45) or the rate constant reflecting SERCA activity (ATX-II vs ATX-II + CNP: 4.6 ± 0.3 s −1 vs 6.9 ± 0.75 s −1 , n cells/hearts = 17/5 vs 11/5, P = .08; ATX-II vs ATX-II + CNP + Ocn: 4.6 ± 0.3 s −1 vs 5.9 ± 0.05 s −1 , n cells/hearts = 17/5 vs 17/5, P = .43). ( E–H ) Sac as well as Sac + Ocn did not significantly change caffeine-induced Ca 2+ -transient amplitude (ATX-II vs ATX-II + Sac: ΔF 405 /F 485 : 0.18 ± 0.04 vs 0.14 ± 0.012, n cells/hearts = 15/5 vs 18/5, P = .67;, ATX-II vs ATX-II + Sac + Ocn: ΔF 405 /F 485 : 0.18 ± 0.04 vs 0.24 ± 0.03, n cells/hearts = 15/5 vs 16/5, P = .36), RT-50 (ATX-II vs ATX-II + Sac: 0.7 ± 0.07 s vs 0.9 ± 0.1 s, n cells/hearts = 12/5 vs 17/5, P = .59; ATX-II vs ATX-II + Sac + Ocn: 0.7 ± 0.07 s vs 0.93 ± 0.17 s, n cells/hearts = 12/5 vs 11/5, P = .55) and the rate constant compared with ATX-II (ATX-II vs ATX-II + Sac: 4.9 ± 0.46 s −1 vs 4.9 ± 0.51 s −1 , n cells/hearts = 15/5 vs 17/5, P = .95; ATX-II vs ATX-II + Sac + Ocn: 4.9 ± 0.46 s −1 vs 5.6 ± 0.44 s −1 , n cells/hearts = 15/5 vs 16/5, P = .98). A one-way ANOVA with a Tukey post hoc test was used for the statistical analysis. * = P < .05; *** = P < .001
Article Snippet: The late sodium current (late I Na ) was increased by the addition of ATX-II (5 nmol/l or 0.5 nmol/l, Alomone Labs, Jerusalem, Israel) as described previously to induce an imbalance of Na + -/Ca 2+ -homeostasis mimicking conditions found in heart failure., For the initial proof-of-concept experiments comparing the effects of ANP and CNP, cardiomyocytes were challenged with 5 nmol/L ATX-II to establish a robust arrhythmogenic phenotype.
Techniques: Activity Assay, Analysis